维普期刊资源整合服务平台（V6.5）

32篇 您的检索式：作者名="Waring JF"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Gene expression profiling of multiple histone deaeetylase (HDAC)inhibitors:defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines显示文摘	Glaser KB Stayer MJ Waring JF	2003	Mol Cancer Ther2003，2，2：	1
2	Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors:defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines 显示文摘	Staver MJ Waring JF	2003	Mol Cancer Ther2003，2，2：	1
3	显示文摘	Waring JF	2001	Tox Lett2001，120，：	1
4	Role of GSK-3 activation and a7 nAChRs in Al-42-induced tau phosphoryla- tion in PC12 cells显示文摘	Hu M Waring JF Gopalakrishnan M	2008	J Neurochem2008，106，：	1
5	显示文摘	Waring JF	2001	Toxicol Appl Pharmacol2001，175，：	1
6	Identifying toxic mechanisms using DNA microarrays: evidence that an experimental inhibitor of cell adhesion molecule expression signals through the aryl hydrocarbon nuclear receptor 显示文摘	Waring JF Gum R Morfitt D	2002	Toxicology2002，，：	1
7	Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA earcinoma cell lines显示文摘	Glaser KB Stayer MJ Waring JF	2003	Mol Cancer Ther2003，2，2：	1
8	A human immunodeficiency virus protease inhibi tot is a novel functional inhibitor of human pregnane X receptor显示文摘	Healan-Greenberg C Waring JF Kempf DJ	2008	Drug Metab Dispos2008，36，3：	1
9	The MOS 36-Item Short- Form Health Survey (SF-36) :test of data quality, scaling assump- tions,and reliadility across diverse patient groups显示文摘	McHorney CA Ware JE Jr Lu JF	1994	Med Care1994，32，1：	1
10	The MOS 36-item ShortForm Health Survey ( SF-36), Ⅲ: tests of data quality, scaling assumptions, and reliability across diverse patient groups 显示文摘	McHomey CA Ware JE Jr Lu JF	1994	Med Care1994，32，：	1
11	Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity 显示文摘	Waring JF Ciurlionis R Jolly RA	2001	Toxicol Lett2001，120，13：	1
12	Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles显示文摘	Waring JF Jolly RA Ciurlionis R Lum PY Praestgaard JT Morfitt DC	2001	Toxicol Appl Pharmacol2001，175，1：	1
13	Development of a DNA microarray for toxicology based on hepatotoxin-regulated sequences 显示文摘	Cavet G Jolly RA	2003	Environ Health Perspect2003，111，6：	1
14	Toxicogenomics in drug discovery: from preclinical studies to clinical trials显示文摘	YANG Y BLOMME EA WARING JF	2004	Chem Biol Interact2004，150，1：	1
15	Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles显示文摘	Waring JF Jolly RA Ciurlionis R	2001	Toxicol Appl Pharmacol2001，175，1：	1
16	Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles显示文摘	Waring JF Jolly RA Clurlionis R	2001	Toxicol Appl Pharmacol2001，175，1：	1
17	Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles显示文摘	Jolly RA Ciurlionis R	2001	Toxicol Appl Pharmacol2001，175，1：	1
18	The MOS 36-Item Short-Form Health Survey (SF-36),Ⅲ:tests of data quality,scaling assumptions,and reliability across diverse patient groups显示文摘	McHorney CA Ware JE Jr Lu JF		0，，01：	1
19	In vitro reveals a correlation between gene expression profiles and mechanisms of toxicity显示文摘	Ciurlionis R Jolly RA	2001	Toxicol Lett2001，120，13：	1
20	Development of an approach for ab initio estimation of compound-induced liver injury based on global gene transcriptional profiles显示文摘	Dai X He YD Dai H Lum PY Roberts CJ Waring JF	2006	Genome Inform2006，17，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示